Orphan drug designation rules to be largely revised for rapid development

Published: 2018-06-07 16:28:00
Updated: 2018-06-07 17:50:55

In order to enlarge therapy options for rare or incurable disease patients, regulations about designation of orphan drugs will be modified.

The Ministry of Food and Drug Safety(MFDS) pre-announced the partial revision bill to the ‘Regulations about Designation of Orphan Drugs’ which mainly conta...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.